New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 5, 2013
10:07 EDTALKS, OKE, CCO, CAJ, EOG, XEC, SN, NBL, FST, MS, SJM, XOM, C, QLTYOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Alkermes (ALKS) downgraded to Neutral from Buy at UBS... Citigroup (C) downgraded to Hold from Buy at Deutsche Bank... Exxon Mobil (XOM) downgraded to Outperform from Strong Buy at Raymond James... J.M. Smucker (SJM) downgraded to Underperform from Market Perform at Wells Fargo... Morgan Stanley (MS) downgraded to Hold from Buy at Deutsche Bank... Forest Oil (FST) downgraded to Underperform from Neutral at Macquarie... Noble Energy (NBL) downgraded to Neutral from Outperform at Macquarie... Sanchez Energy (SN) downgraded to Neutral from Outperform at Macquarie... Cimarex Energy (XEC) downgraded to Neutral from Outperform at Macquarie.. EOG Resources (EOG) downgraded to Neutral from Outperform at Macquarie... Canon (CAJ) downgraded to Sell from Neutral at Goldman... Clear Channel Outdoor (CCO) downgraded at B. Riley... ONEOK (OKE) downgraded to Hold from Buy at Argus... Quality Distribution (QLTY) downgraded to Hold from Buy at Stifel.
News For ALKS;C;XOM;SJM;MS;FST;NBL;SN;XEC;EOG;CAJ;CCO;OKE;QLTY From The Last 14 Days
Check below for free stories on ALKS;C;XOM;SJM;MS;FST;NBL;SN;XEC;EOG;CAJ;CCO;OKE;QLTY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
April 8, 2014
14:43 EDTALKSAlkermes price target rasied to $66 from $60 at Leerink
14:11 EDTNBLWoodside expected to reach deal with Israel on Leviathan tax, Globes says
Subscribe for More Information
09:35 EDTCActive equity options trading on open
Subscribe for More Information
09:00 EDTALKSAlkermes rises 7.4%
Alkermes is up 7.4%, or $3.03, to $44.13
07:47 EDTALKSAlkermes to host conference call
Subscribe for More Information
07:04 EDTALKSAlkermes announces phase 3 'positive' results from aripiprazole lauroxil study
Alkermes announced "positive" topline results from a randomized, double-blind, placebo-controlled phase 3 clinical trial of aripiprazole lauroxil in patients with schizophrenia. Patients treated once monthly with either 441 mg or 882 mg of aripiprazole lauroxil demonstrated statistically significant reductions from baseline in Positive and Negative Syndrome Scale total scores at week 12, compared to placebo, which was the prespecified primary endpoint in the study. Based on the positive results from this phase 3 study, Alkermes plans to submit a New Drug Application to the U.S. Food and Drug Administration in 3Q14. In addition to meeting the prespecified primary efficacy endpoint, the study also met the prespecified key secondary endpoint of improvement on the Clinical Global Impression-Improvement scale versus placebo at week 12. Aripiprazole lauroxil was generally well tolerated in the phase 3 study, and the safety profile of aripiprazole lauroxil was similar to that reported with oral aripiprazole. The most common adverse events in the study were insomnia, akathisia and headache. Alkermes will present data from the phase 3 study at an upcoming medical meeting and submit the results for publication in a peer-reviewed journal.
06:41 EDTCCitigroup plans to close one third of Korea branches, Reuters says
Citigroup announced that it is planning to close nearly one third of its Korea branches, which makes it the third global bank to reduce its presence in the country in the last year due to increasing expenses and intense competition, according to Reuters, citing a statement from the bank. Reference Link
06:24 EDTCCitigroup may miss return-on-tangible-common-equity goal, WSJ reports
According to sources, Citigroup may miss a its 2015 target for return-on-tangible-common-equity after the Federal Reserve last month rejected the bank's capital plan, the Wall Street Journal reports. The Fed denied Citigroup's proposal to boost its dividend and increase stock buybacks on March 26, making it unlikely Citigroup can meet this key profitability target. Reference Link
April 7, 2014
19:57 EDTMS, CFederal Reserve announces extension on some CLOs
The Federal Reserve Board announced that it intends to exercise its authority to give banking entities two additional one-year extensions to conform their ownership interests in and sponsorship of certain collateralized loan obligations, or CLOs, covered by section 619 of the Dodd-Frank Wall Street Reform and Consumer Protection Act, commonly referred to as the Volcker rule. Section 619 of the Dodd-Frank Act directed the board to adopt rules for the conformance period and the board previously extended the conformance period for all activities and investments by one year to July 21, 2015. To ensure effective compliance, the board intends to grant banking entities two additional one-year extensions, which together would extend until July 21, 2017, to conform their ownership interests in and sponsorship of CLOs to the statute. Publicly traded companies that may be impacted by the announcement include Bank of America (BAC), Citigroup (C), Goldman Sachs (GS), JPMorgan (JPM), Morgan Stanley (MS), U.S. Bancorp (USB) and Wells Fargo (WFC). Reference Link
17:16 EDTCCitigroup to resolve certain private-label securitization repurchase claims
Subscribe for More Information
16:01 EDTCOptions Update; April 7, 2014
Subscribe for More Information
10:00 EDTCOn The Fly: Analyst Upgrade Summary
Agios Pharmaceuticals (AGIO) upgraded to Overweight from Neutral at JPMorgan... Alcoa (AA) upgraded to Hold from Sell at Deutsche Bank... Align Technology (ALGN) upgraded to Outperform from Market Perform at Barrington... Analog Devices (ADI) upgraded to Neutral from Sell at Goldman... B&G Foods (BGS) upgraded to Outperform from Sector Perform at RBC Capital... Citigroup (C) upgraded to Neutral from Underweight at HSBC... Intel (INTC) upgraded to Outperform from Sector Perform at Pacific Crest... JetBlue (JBLU) upgraded to Neutral from Sell at Goldman... Kindred Healthcare (KND) upgraded to Outperform from Sector Perform at RBC Capital... Lennox (LII) upgraded to Outperform from Market Perform at Wells Fargo... Newmont Mining (NEM) upgraded to Hold from Sell at Deutsche Bank... PBF Energy (PBF) upgraded to Buy from Neutral at Citigroup... Renasant (RNST) upgraded to Outperform from Market Perform at Raymond James... Select Medical (SEM) upgraded to Outperform from Sector Perform at RBC Capital... Ultra Petroleum (UPL) upgraded to Outperform from Market Perform at Raymond James... Under Armour (UA) upgraded to Buy from Neutral at Sterne Agee... Hercules Technology (HTGC) upgraded to Buy from Hold at Sandler ONeill... Standard Pacific (SPF) upgraded to Outperform from Market Perform at Raymond James... Yelp (YELP) upgraded to Outperform from Perform at Oppenheimer... Netflix (NFLX) upgraded to Outperform from Perform at Oppenheimer... Pandora (P) upgraded to Outperform from Neutral at Wedbush.
06:58 EDTMS, CDark markets could cause more harm than high-frequency trading, Reuters says
After a book by financial author Michael Lewis sparked worries that high-speed traders have been rigging the U.S. stock market, former regulators and academics say a more serious threat to investors could be the increasing amount of trading that happens outside of exchanges, reported Reuters. Top internalizers include units of KCG Holdings (KCG), Citadel, UBS (UBS), and Citigroup (C). Dark pool operators include Credit Suisse (CS) and Morgan Stanley (MS). In an attempt to earn back some of the retail orders, exchanges such as IntercontinentalExchange Group's (ICE) New York Stock Exchange, Nasdaq (NDAQ), and BATS Global Markets, have allowed brokerages to place dark pool-style orders on their platforms, with the trade hidden until after it is executed. Reference Link
06:05 EDTCCitigroup upgraded to Neutral from Underweight at HSBC
HSBC upgraded Citigroup to Neutral citing the recent underperformance of shares. The firm raised its price target for the stock to $51 from $48.
April 4, 2014
16:00 EDTCOptions Update; April 4, 2014
iPath S&P 500 VIX Short-Term Futures up 89c to 41.88. Option volume leaders: AAPL C P NFLX LNG BAC INTC TSLA TWTR according to Track Data.
08:49 EDTMSMorgan Stanley well positioned to beat Q1 Street expectations, says Macquarie
Macquarie said Morgan Stanley is best positioned to beat Q1 Street expectations of 62c due to mix and easier comps.
07:49 EDTEOGEOG Resources price target raised to $120 from $100 at Stifel
Subscribe for More Information
07:27 EDTMSMorgan Stanley pushes back at HFT accusations, FT says
Subscribe for More Information
07:25 EDTEOG, NBLAnadarko price target raised to $120-$130 from $110-$120 at Wells Fargo
Wells Fargo increased its price target on Anadarko after the company announced that it had settled the Tronox case for a lower than expected amount. The firm thinks the stock's discount to its peers EOG Resources (EOG) and Noble Energy (NBL) is unjustified. Wells keeps an Outperform rating on Anadarko.
06:29 EDTFSTForest Oil reinstated with an Underperform at BofA/Merrill
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use